AAAAAA
Results:
1-8
|
Results: 8
Authors:
Fortune, JM
Lavrukhin, OV
Gurnon, JR
Van Etten, JL
Lloyd, RS
Osheroff, N
Citation: Jm. Fortune et al., Topoisomerase II from Chlorella virus PBCV-1 has an exceptionally high DNAcleavage activity, J BIOL CHEM, 276(26), 2001, pp. 24401-24408
Authors:
Durrieu, F
Samejima, K
Fortune, JM
Kandels-Lewis, S
Osheroff, N
Earnshaw, WC
Citation: F. Durrieu et al., DNA topoisomerase II alpha interacts with CAD nuclease and is involved in chromatin condensation during apoptotic execution, CURR BIOL, 10(15), 2000, pp. 923-926
Authors:
Fortune, JM
Osheroff, N
Citation: Jm. Fortune et N. Osheroff, Topoisomerase II as a target for anticancer drugs: When enzymes stop beingnice, PROG NUCL A, 64, 2000, pp. 221-253
Authors:
Lavrukhin, OV
Fortune, JM
Wood, TG
Burbank, DE
Van Etten, JL
Osheroff, N
Lloyd, RS
Citation: Ov. Lavrukhin et al., Topoisomerase II from Chlorella virus PBCV-1 - Characterization of the smallest known type II topoisomerase, J BIOL CHEM, 275(10), 2000, pp. 6915-6921
Authors:
Kingma, PS
Fortune, JM
Osheroff, N
Citation: Ps. Kingma et al., Topoisomerase II-catalyzed ATP hydrolysis as monitored by thin-layer chromatography, METH MOL B, 95, 2000, pp. 51-56
Authors:
Fortune, JM
Osheroff, N
Citation: Jm. Fortune et N. Osheroff, Topoisomerase II-catalyzed relaxation and catenation of plasmid DNA, METH MOL B, 95, 2000, pp. 275-281
Authors:
Byl, JAW
Fortune, JM
Burden, DA
Nitiss, JL
Utsugi, T
Yamada, Y
Osheroff, N
Citation: Jaw. Byl et al., DNA topoisomerases as targets for the anticancer drug TAS-103: Primary cellular target and DNA cleavage enhancement, BIOCHEM, 38(47), 1999, pp. 15573-15579
Authors:
Fortune, JM
Velea, L
Graves, DE
Utsugi, T
Yamada, Y
Osheroff, N
Citation: Jm. Fortune et al., DNA topoisomerases as targets for the anticancer drug TAS-103: DNA interactions and topoisomerase catalytic inhibition, BIOCHEM, 38(47), 1999, pp. 15580-15586
Risultati:
1-8
|